ERP for Pharma connects material purchasing, production and financial records with batch release reviews and stability studies. Products, bill of materials and Routings define what is made; Lots retain supplier, production and expiry context.
Lots in one list
Approver reviews the commitment independently of Buyer under the agreed spending policy.
Every feature works on the same records. Pick one to see the screen your team works in.
Connect batch review decisions with certificate, expiry and stability evidence.
Approval conditions
| Batch | QA reviewer | Certificate number | Expiry date | Status | |
|---|---|---|---|---|---|
| Cough syrup, lot CS26106 | Owen Hart | BRR-70718 | 16 Oct | Pending | |
| Zinc tablets, lot ZT26102 | Mei Tan | BRR-54620 | 25 Oct | Pending | |
| Antacid tablets, lot AT26104 | Luis Moreno | BRR-75361 | 22 Oct | Pending | |
| Zinc tablets, lot ZT26102 | Mei Tan | BRR-23354 | 18 Oct | Pending | |
| Barrier cream, lot BC26108 | Sanjay Patel | BRR-96951 | 03 Nov | Pending |
Maintain product identity, dated bills of material and the routing used by production.
Bill of materials
| BOM number | Product | Version | Effective from | Effective to | Status | |
|---|---|---|---|---|---|---|
| BOM-17457 | Cough syrup, 100 ml | Version 1.0 | 21 Oct | 29 Oct | Active | |
| BOM-22062 | Electrolyte sachets, 10 pack | Version 1.1 | 23 Oct | 26 Oct | Active | |
| BOM-11863 | Oral saline solution, 500 ml | Version 2.0 | 17 Oct | 23 Oct | Active | |
| BOM-42465 | Skin barrier cream, 50 g | Version 2.1 | 14 Oct | 22 Oct | Active | |
| BOM-23854 | Vitamin D drops, 400 IU, 30 ml | Version 3.0 | 01 Nov | 05 Nov | Active |
Plan supply, assign operations and distinguish reported throughput from accepted finished output.
Work order operations
| Work order | Operation number | Description | Planned start | Planned end | Status | |
|---|---|---|---|---|---|---|
| Electrolyte sachets, batch 26105 | 30 | Blend solution to approved batch record | 03 Nov | 05 Nov | Pending | |
| Antacid tablets, batch 26104 | 50 | Verify tablet weight every 30 minutes | 19 Oct | 23 Oct | In progress | |
| Zinc tablets 25 mg, batch 26102 | 60 | Fill bottles under line clearance | 23 Oct | 01 Nov | Completed | |
| Oral saline 500 ml, batch 26101 | 10 | Inspect blister seal integrity | 26 Oct | 28 Oct | Pending | |
| Iron tablets 18 mg, batch 26107 | 50 | Label cartons against master artwork | 12 Oct | 21 Oct | In progress |
Review purchase commitments and retain incoming inspection context before material becomes usable.
Purchase orders
| Purchase order number | Vendor | Order date | Required date | Status | Buyer | |
|---|---|---|---|---|---|---|
| PO-28423 | Riverbend Carton Supply | 13 Oct | 19 Oct | Draft | Fatima Okafor | |
| PO-54863 | Eastfield Excipient Co. | 10 Oct | 17 Oct | Submitted | Nadia Karim | |
| PO-22390 | Cedar Grove Ingredients | 12 Oct | 20 Oct | Approved | Sanjay Patel | |
| PO-79526 | Harborline Closure Co. | 10 Oct | 16 Oct | Partially received | Owen Hart | |
| PO-98859 | Cedar Grove Ingredients | 14 Oct | 21 Oct | Received | Sanjay Patel |
Review stock availability, lot expiry and recorded movement references through production and delivery.
Quality holds
| Hold number | Hold type | Lot | Goods receipt | Work order | Placed date | |
|---|---|---|---|---|---|---|
| QH-26144 | Lot | Zinc tablets, lot ZT26102 | Blister foil receipt, Oct 16 | Vitamin D drops 400 IU, batch 26103 | 12 Oct | |
| QH-17569 | Goods receipt | Vitamin D drops, lot VD26103 | Zinc citrate receipt, Oct 14 | Iron tablets 18 mg, batch 26107 | 23 Oct | |
| QH-91738 | Work order operation | Cough syrup, lot CS26106 | Saline cartons receipt, Oct 18 | Zinc tablets 25 mg, batch 26102 | 01 Nov | |
| QH-96078 | Lot | Barrier cream, lot BC26108 | Amber bottles receipt, Oct 15 | Skin barrier cream 50 g, batch 26108 | 26 Oct | |
| QH-48542 | Goods receipt | Barrier cream, lot BC26108 | Amber bottles receipt, Oct 15 | Iron tablets 18 mg, batch 26107 | 31 Oct |
Record inspection evidence, contain affected material and distinguish corrective-action completion from verification.
Approval conditions
| Receipt number | Purchase order | Receipt date | Warehouse | Received by | Status | |
|---|---|---|---|---|---|---|
| GR-42385 | Amber bottles purchase, October | 20 Oct | WIP staging room | Nadia Karim | Pending QC | |
| GR-71906 | Cream base purchase, December | 15 Oct | Packaging components store | Sanjay Patel | Pending QC | |
| GR-29223 | Zinc citrate purchase, October | 12 Oct | Released ingredients warehouse | Luis Moreno | Pending QC | |
| GR-60963 | Sorbitol purchase, November | 14 Oct | Finished goods warehouse | Sanjay Patel | Pending QC | |
| GR-49326 | Tablet coating purchase, January | 21 Oct | Released ingredients warehouse | Anika Rao | Pending QC |
Match supplier invoices, review standard costs and reconcile postings within accounting periods.
Supplier invoices
| Invoice number | Supplier | Purchase order | Goods receipt | Amount | Due date | |
|---|---|---|---|---|---|---|
| SI-48241 | Northbank Bottle Works | Zinc citrate purchase, October | Sorbitol receipt, Oct 17 | 450 | 23 Oct | |
| SI-87844 | Riverbend Carton Supply | Cream base purchase, December | Amber bottles receipt, Oct 15 | 610 | 04 Nov | |
| SI-33955 | Willow Chemical Supply | Cartons for saline, December | Bottle caps receipt, Oct 21 | 80 | 23 Oct | |
| SI-45865 | Harborline Closure Co. | Tablet coating purchase, January | Amber bottles receipt, Oct 15 | 810 | 03 Nov | |
| SI-42745 | Northbank Bottle Works | Cartons for saline, December | Blister foil receipt, Oct 16 | 220 | 02 Nov |
From demand to reviewed batch delivery ships ready to use. 2 steps need a named approval before the work moves on: Purchase approval (Approver) and Batch release approval (Industry Reviewer).
Review customer demand and supply proposals before releasing production against the selected bill and route.
Have Approver review the purchasing commitment independently of its preparer.
Record incoming material and the required inspection disposition before it becomes usable stock.
Receive previously unreceived accepted terminal output with required quality decisions resolved.
Bring batch, reviewer, certificate and expiry evidence to Industry Reviewer before the release decision.
Record eligible delivery once and reconcile its invoice and financial effects within the accounting period.
Open any lot to see its batch release reviews, the roles that work on it, its process stages and its approvals on one page.
Lot number, Product, Received date and Expiry date.
Each line is linked to this lot.
Industry Reviewer and Industry Specialist, each with their own permissions.
Execute production, with the role that acts.
Purchase approval and Batch release approval, with who decides.
Electrolyte sachets, 10 pack · Available
| Batch | QA reviewer | Certificate number |
|---|---|---|
| Cough syrup, lot CS26106 | Owen Hart | BRR-70718 |
| Zinc tablets, lot ZT26102 | Mei Tan | BRR-54620 |
| Antacid tablets, lot AT26104 | Luis Moreno | BRR-75361 |
Signed in as Approver
| Decision | Approver | |
|---|---|---|
| Purchase approvalHave Approver review the purchasing commitment independently of its preparer. | Approver | |
| Batch release approvalBring batch, reviewer, certificate and expiry evidence to Industry Reviewer before the release decision. | Industry Reviewer |
Everyone opens Pharma ERP to the work that is theirs. Pick a role to see what it starts with.
Owns MRP, work-order release, scheduling, and BOM/Routing maintenance.
This is the first screen this role sees.
Work order operations · Production Planner
| Work order | Operation number | Work center | Operator | Planned start | Planned end | |
|---|---|---|---|---|---|---|
| Vitamin D drops 400 IU, batch 26103 | 70 | Cream mixing vessel 2 | Marco Bellini | 26 Oct | 01 Nov | |
| Electrolyte sachets, batch 26105 | 10 | Liquid filling line 2 | Elena Voss | 19 Oct | 26 Oct | |
| Electrolyte sachets, batch 26105 | 30 | Powder blending room 3 | Nadia Karim | 27 Oct | 30 Oct | |
| Oral saline 500 ml, batch 26101 | 50 | Powder blending room 3 | Owen Hart | 18 Oct | 21 Oct | |
| Skin barrier cream 50 g, batch 26108 | 70 | Powder blending room 3 | Fatima Okafor | 24 Oct | 30 Oct |
Performs inspections and dispositions non-conforming material.
This is the first screen this role sees.
Goods receipts · Quality Inspector
| Receipt number | Purchase order | Receipt date | Warehouse | Received by | Status | |
|---|---|---|---|---|---|---|
| GR-42385 | Amber bottles purchase, October | 20 Oct | WIP staging room | Nadia Karim | Pending QC | |
| GR-71906 | Cream base purchase, December | 15 Oct | Packaging components store | Sanjay Patel | Pending QC | |
| GR-29223 | Zinc citrate purchase, October | 12 Oct | Released ingredients warehouse | Luis Moreno | Pending QC | |
| GR-60963 | Sorbitol purchase, November | 14 Oct | Finished goods warehouse | Sanjay Patel | Pending QC | |
| GR-49326 | Tablet coating purchase, January | 21 Oct | Released ingredients warehouse | Anika Rao | Pending QC |
Executes assigned production operations; separately assigned receiving and stock-handling permissions cover warehouse work.
This is the first screen this role sees.
Work order operations · Operator
| Work order | Operation number | Work center | Operator | Planned start | Planned end | |
|---|---|---|---|---|---|---|
| Vitamin D drops 400 IU, batch 26103 | 70 | Cream mixing vessel 2 | Marco Bellini | 26 Oct | 01 Nov | |
| Electrolyte sachets, batch 26105 | 10 | Liquid filling line 2 | Elena Voss | 19 Oct | 26 Oct | |
| Electrolyte sachets, batch 26105 | 30 | Powder blending room 3 | Nadia Karim | 27 Oct | 30 Oct | |
| Oral saline 500 ml, batch 26101 | 50 | Powder blending room 3 | Owen Hart | 18 Oct | 21 Oct | |
| Skin barrier cream 50 g, batch 26108 | 70 | Powder blending room 3 | Fatima Okafor | 24 Oct | 30 Oct |
Runs the floor - assigns operators, posts production, handles holds.
This is the first screen this role sees.
Work order operations · Shop Floor Supervisor
| Work order | Operation number | Work center | Operator | Planned start | Planned end | |
|---|---|---|---|---|---|---|
| Vitamin D drops 400 IU, batch 26103 | 70 | Cream mixing vessel 2 | Marco Bellini | 26 Oct | 01 Nov | |
| Electrolyte sachets, batch 26105 | 10 | Liquid filling line 2 | Elena Voss | 19 Oct | 26 Oct | |
| Electrolyte sachets, batch 26105 | 30 | Powder blending room 3 | Nadia Karim | 27 Oct | 30 Oct | |
| Oral saline 500 ml, batch 26101 | 50 | Powder blending room 3 | Owen Hart | 18 Oct | 21 Oct | |
| Skin barrier cream 50 g, batch 26108 | 70 | Powder blending room 3 | Fatima Okafor | 24 Oct | 30 Oct |
Reviews exact specialty evidence and authorizes its domain release gate.
This is the first screen this role sees.
Batch release reviews · Industry Reviewer
| Batch | QA reviewer | Certificate number | Expiry date | Status | |
|---|---|---|---|---|---|
| Cough syrup, lot CS26106 | Owen Hart | BRR-70718 | 16 Oct | Pending | |
| Zinc tablets, lot ZT26102 | Mei Tan | BRR-54620 | 25 Oct | Pending | |
| Antacid tablets, lot AT26104 | Luis Moreno | BRR-75361 | 22 Oct | Pending | |
| Zinc tablets, lot ZT26102 | Mei Tan | BRR-23354 | 18 Oct | Pending | |
| Barrier cream, lot BC26108 | Sanjay Patel | BRR-96951 | 03 Nov | Pending |
Maintains assigned ERP for Pharma specialty evidence.
This is the first screen this role sees.
Lots · Industry Specialist
Makes assigned purchasing and control decisions independently of the person who requested or prepared them.
This is the first screen this role sees.
Purchase orders · Approver
| Purchase order number | Vendor | Order date | Required date | Total amount | Buyer | |
|---|---|---|---|---|---|---|
| PO-37345 | Northbank Bottle Works | 13 Oct | 19 Oct | $18,420.00 | Fatima Okafor | |
| PO-17280 | Harborline Closure Co. | 19 Oct | 28 Oct | $7,890.00 | Mei Tan | |
| PO-97873 | Willow Chemical Supply | 16 Oct | 22 Oct | $12,350.00 | Owen Hart | |
| PO-57558 | Cedar Grove Ingredients | 17 Oct | 25 Oct | $5,640.00 | Owen Hart | |
| PO-50868 | Cedar Grove Ingredients | 20 Oct | 25 Oct | $9,175.00 | Hana Sato |
Owns the general ledger, payables, and receivables for manufacturing transactions.
This is the first screen this role sees.
Cost rollups · Accountant
Manages procurement of raw materials and components.
This is the first screen this role sees.
Purchase orders · Buyer
| Purchase order number | Vendor | Order date | Required date | Total amount | Buyer | |
|---|---|---|---|---|---|---|
| PO-37345 | Northbank Bottle Works | 13 Oct | 19 Oct | $18,420.00 | Fatima Okafor | |
| PO-17280 | Harborline Closure Co. | 19 Oct | 28 Oct | $7,890.00 | Mei Tan | |
| PO-97873 | Willow Chemical Supply | 16 Oct | 22 Oct | $12,350.00 | Owen Hart | |
| PO-57558 | Cedar Grove Ingredients | 17 Oct | 25 Oct | $5,640.00 | Owen Hart | |
| PO-50868 | Cedar Grove Ingredients | 20 Oct | 25 Oct | $9,175.00 | Hana Sato |
Review batch evidence, stock exposure, production output and financial exceptions.
This quarter
How far records got this quarter
| Stage | Reached | Step | |
|---|---|---|---|
| Available | 28 | ||
| Quarantine | 18 | 64% | |
| On hold | 10 | 56% | |
| Consumed | 7 | 70% |
Sample totals per stage
Which batches remain Pending or Testing, who is attributed as reviewer, and which certificate or expiry evidence needs examination?
Which dated pulls remain Pending or Investigate, and what result is retained for the batch and storage condition?
Which current lot quantities are available, held or expired, and which expiry dates fall within the review window?
Which corrective work is overdue or Completed without independent verification?
How does on-hand stock compare with allocated quantity and the dated reservations that require it?
Which invoice exceptions remain unresolved, how do invoiced and expected values differ, and who owns investigation?
How much good and scrapped output was reported within completed production-log intervals for a work order or work center?
Which dated entries remain Draft, and how do posted debit and credit lines reconcile within the accounting period?
Which effective version carries the current material, labor, overhead and outside-processing values for the product?
See how Pharma ERP fits your kind of team.
Connect purchased material, shop-floor output and the batch quality decision.
Review supplier lots, incoming quality and expiry before allocating delivery stock.
Keep batch release evidence, dated stability pulls and corrective-action verification connected.
Each stage, from demand to reviewed batch delivery, names the role that acts and the status it records, so a change is never anonymous.
Each stage, the role that acts and the status it records
Prepare batch evidence and operational exceptions while preserving human decisions.
Set up connections through ERP.AI and Proto workflows, with every change logged.
Every record lives in a table you can see, extend and export. Add fields or whole tables in Proto.
Browse all 70 tablesStart with one team and one process, then add the rest once the basics are running.
Select a product, incoming supplier lot and production order the operations and quality owners can review together. Include its batch release and stability follow-up. Keep external laboratory execution, signatures and regulatory submissions within their separately agreed systems.
Reconcile products and supplier-to-vendor identity, then the selected bill and route. Map the specialty reviewer to their user account and verify the employee mapping used by assigned-work and purchase views. Import lot and certificate evidence with original identifiers and dates.
Set up the operating views and reports with their named owners. Agree the controlled purchasing and batch decision routes and test them with the reviewer accounts. Confirm who can perform floor commands and who records the resulting production evidence.
Attempt issue from an expired or held lot, a duplicate receipt and a repeated accepted completion. Try an inspection with an overdue instrument and self-verification of corrective work. Each rejected command must leave its affected quantity and financial result unchanged.
Capture the pilot batch review with the correct quality reviewer and certificate context. Reject repeated evidence identities. Rehearse a stability correction through the attributed successor-evidence route; review the original and successor evidence together before accepting the correction.
$0per user
The base account and everyday work in the ERP.AI app are free, for every user.
| Usage | Per $1 |
|---|---|
| Record reads (list, filter, get) | 20,000 |
| Search or aggregate queries | 4,000 |
| Record writes | 4,000 |
| Imported or synced records | 200,000 |
| Workflow runs | 2,000 |
| AI agent runs | 2,000 |
| Scheduled jobs or webhooks | 20,000 |
| File uploads (MB) | 2,000 |
| CSV or PDF exports | 100 |
Click Get started, then use Proto to configure ERP for Pharma for your business. Start with a reviewed product definition, an incoming supplier lot and a production order. Follow accepted output through batch review and a stability pull, then reconcile its stock and financial effects before expanding.
The Batch Release Reviews screen presents a batch release review queue, status distribution, certificate and expiry evidence, and selected-record review history. The batch release review links the review to lots and quality reviewer in the person record. Confirm the reviewer account mapping and controlled decision route during setup.
The batch review status records the specialty decision. The quality hold retains its own disposition and release attribution. Rehearse the operating controls that connect eligible production and shipment to required quality decisions; review both decisions before treating the material as usable.
Each stability study records batch, storage condition, pull date, result and disposition. Pending, Accept and Investigate separate the evidence states. Configure the correction route to retain original evidence and attributed successors, then reject repeated capture of the same source evidence.
Separate evidence preparation from the human decision. Agree the permitted approval route with Industry Reviewer and Approver, then rehearse it using their actual accounts. The preparer must be refused if they attempt to approve their own purchasing commitment.
Each lot carries expiry date and status. Require lot-controlled issue to use an Available, unexpired lot of the intended product. Rehearse the expiry boundary and unresolved holds against actual movement commands before relying on the control.
Use the lab's approved result records and the controlled-document system agreed with your quality owner. Map each result to the correct batch, retain its actual evidence date and review corrections against the original. Agree provider access and the acceptance checks before enabling the connection.
Connections require explicit configuration, provider access and source mappings. Agree the source owner and permitted operating command for each feed. Rehearse duplicate events, wrong references and external failures before enabling a feed; see integrations.
Bind each receipt, completion, shipment and material posting to its actual source identity so retries return the original effect. Test repeated commands and conflicting content during implementation. Batch review and stability capture must not create another physical or financial effect.
Use the pricing page for the published policy. Agree implementation scope after reviewing your reference mappings, approval routes and required connections. The implementation plan sets out the pilot evidence to review before wider cutover.
Start free, then use Proto to change fields, steps and approvals before your team goes live.